This page in English
Laddar profil information

Publikationer

Glioblastoma and glioblastoma stem cells are dependent on functional MTH1
Pudelko L, Rouhi P, Sanjiv K, Gad H, Kalderén C, Höglund A, et al
Oncotarget 2017;8(49):84671-84684

PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status
Roodakker Kr, Elsir T, Edqvist Phd, Hagerstrand D, Carison J, Lysiak M, et al
ONCOTARGET 2016;7(45):72431-72442

TRAF2 is an NF-kappa B-activating oncogene in epithelial cancers
Shen Rr, Zhou Ay, Kim E, O'connell Jt, Hagerstrand D, Beroukhim R, et al
ONCOGENE 2015;34(2):209-16

Systematic Interrogation of 3q26 Identifies TLOC1 and SKIL as Cancer Drivers
Hagerstrand D, Tong A, Schumacher Se, Ilic N, Shen Rr, Cheung Hw, et al
CANCER DISCOVERY 2013;3(9):1044-57

Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile
Hägerstrand D, He X, Bradic Lindh M, Hoefs S, Hesselager G, Ostman A, et al
Neuro-oncology 2011;13(11):1178-91

Chimeric tyrosine kinase-HDAC inhibitors as antiproliferative agents
Uecker A, Sicker M, Beckers T, Mahboobi S, Hagerstrand D, Ostman A, et al
ANTI-CANCER DRUGS 2010;21(8):759-65

PI3K/PTEN/Akt pathway status affects the sensitivity of high-grade glioma cell cultures to the insulin-like growth factor-1 receptor inhibitor NVP-AEW541
Hägerstrand D, Lindh Mb, Peña C, Garcia-echeverria C, Nistér M, Hofmann F, et al
Neuro-oncology 2010;12(9):967-75

Gene expression analyses of grade II gliomas and identification of rPTPbeta/zeta as a candidate oligodendroglioma marker
Hägerstrand D, Smits A, Eriksson A, Sigurdardottir S, Olofsson T, Hartman M, et al
Neuro-oncology 2008;10(1):2-9

Characterization of an imatinib-sensitive subset of high-grade human glioma cultures
Hägerstrand D, Hesselager G, Achterberg S, Wickenberg Bolin U, Kowanetz M, Kastemar M, et al
Oncogene 2006;25(35):4913-22

Karta